WHO to study 3 drugs to treat COVID-19

The World Health Organization said Aug. 11 it plans to study three drugs in its ongoing Solidarity trial to see if they are effective in treating hospitalized COVID-19 patients.

The trial will test artesunate, made by Ipca Laboratories, which is used to treat severe malaria; imatinib, made by Novartis, which is used to treat certain cancers; and infliximab, made by Johnson & Johnson, which is used to treat immune system diseases, including Crohn's disease.